SecBot SecBot
DEFA14A ·Filed Apr 28, 2026

IOVA

IOVANCE BIOTHERAPEUTICS, INC.
NEUTRAL
Impact 3/10
Horizondays Processed6mo ago SEC0001104659-26-050467
Proxy solicitation materials
Actionable Insight • Neutral

Monitor for any shareholder dissent on the authorized share increase or compensation votes. The increase in authorized shares could be used for future financing or acquisitions, but no immediate plans disclosed. Trading volume and price action around the June 10 meeting may reflect sentiment on the proposals.

DirectionNeutral
Confidencehigh
Horizondays

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$3.31
T+0 close · Apr 28, 2026 · via day close
Latest settled
+50.76%
T+60 · $4.99
Vs SPY
+46.64%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Apr 29 $3.31entry
  2. T+1 · 7mo ago +1.51%α +0.49% · $3.36
  3. T+5 · 7mo ago +23.57%α +20.45% · $4.09
  4. T+20 · 6mo ago +29.91%α +23.86% · $4.30
  5. T+60 · 4mo ago +50.76%α +46.64% · $4.99

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Iovance Biotherapeutics filed additional definitive proxy materials for its 2026 Annual Meeting, with proposals including director elections, say-on-pay, auditor ratification, an ESPP share increase, and a 30% increase in authorized common stock from 500M to 650M shares. The board recommends 'For' on all items. The filing is routine with no activist or dissident involvement.

Key Financial Metrics

Vote
director election
Meeting
2026-06-10
Seats Contested
6

Key Facts

  • Annual Meeting scheduled for June 10, 2026, voting deadline June 9, 2026
  • Proposal 1: Election of six directors (Iain Dukes, Athena Countouriotis, Ryan Maynard, Wayne P. Rothbaum, Frederick G. Vogt, Michael Weiser)
  • Proposal 5: Increase ESPP shares by 1,000,000
  • Proposal 6: Increase authorized common stock from 500M to 650M shares (30% increase)
  • Board recommends 'For' on all proposals
  • No activist or dissident solicitation; management filed the proxy

Financial Impact

Authorized share increase of 150M shares, potential for future dilution; ESPP increase of 1M shares is minor

dilution

Risk Factors

  • Potential dilution from authorized share increase if fully issued
  • Possible negative vote on say-on-pay or director elections could signal governance concerns

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
76% bullish (17 analysts)

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
DEFA14A Filing (Primary)0001104659-26-050467
Document: 0001104659-26-050467-index-headers.html0001104659-26-050467
Document: 0001104659-26-050467-index.html0001104659-26-050467
Document: 0001104659-26-050467.txt0001104659-26-050467

Track record

21 reports on IOVA

Performance horizon

3 of 4 bullish or bearish reports moved the stock their way by T+20. Best: +121.97% at T+60 after the Jun 10, 2026 report. 5 of 7 went positive at some point.

Filters
  1. Nov 10, 20266d ago SC 13G Neutral 3/10 Entry $8.08 Now $7.55 −6.56% settles Dec 9
  2. Nov 5, 202611d ago 8-K Neutral 4/10 Entry $8.04 Now $7.55 −6.09% settles Dec 7
  3. Nov 5, 202611d ago 8-K Bullish 6/10 Entry $7.74 Now $7.55 −2.45% settles Dec 4
  4. Nov 3, 202613d ago Institutional Cluster Neutral 3/10 Entry $8.70 Now $7.55 −13.22% settles Dec 3
  5. Oct 29, 202618d ago 8-K Bullish 6/10 Entry $8.48 Now $7.55 −10.97% settles Nov 30
  6. Oct 28, 202619d ago Press Release Bullish 7/10 Entry $9.56 Now $7.55 −21.03% settles Nov 27
  7. Oct 5, 20266w ago 8-K Neutral 4/10 Entry $12.96 to $8.65 Now $7.55 −41.74% ▼ −33.25% −30.34% vs SPY
  8. Oct 2, 20266w ago 3 Neutral 2/10 Entry $14.15 to $7.93 Now $7.55 −46.64% ▼ −43.99% −41.42% vs SPY
  9. Sep 29, 20266w ago 8-K Bullish 6/10 Entry $14.45 to $14.58 Now $7.55 −47.75% ▲ +0.90% +0.19% vs SPY
  10. Aug 21, 202612w ago Press Release Neutral 2/10 Entry $8.06 to $10.64 Now $7.55 −6.33% ▲ +32.01% +30.70% vs SPY
Showing 10 of 21

US Market Status

Market Closed · Opens in 6h 7m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Apr 28, 2026